76 related articles for article (PubMed ID: 12908633)
1. The anti-craving taurine derivative acamprosate: failure to extinguish morphine conditioned place preference.
Olive MF
Adv Exp Med Biol; 2003; 526():481-4. PubMed ID: 12908633
[No Abstract] [Full Text] [Related]
2. The anti-relapse compound acamprosate inhibits the development of a conditioned place preference to ethanol and cocaine but not morphine.
McGeehan AJ; Olive MF
Br J Pharmacol; 2003 Jan; 138(1):9-12. PubMed ID: 12522067
[TBL] [Abstract][Full Text] [Related]
3. Anti-craving drugs acamprosate and naloxone do not reduce expression of morphine conditioned place preference in isolated and group-housed rats.
Herzig V; Schmidt WJ
Neurosci Lett; 2005 Feb; 374(2):119-23. PubMed ID: 15644276
[TBL] [Abstract][Full Text] [Related]
4. Acamprosate does not induce a conditioned place preference and reveals no state-dependent effects in this paradigm.
Kratzer U; Schmidt WJ
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):653-6. PubMed ID: 12787853
[TBL] [Abstract][Full Text] [Related]
5. The anti-craving drug acamprosate inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats.
Kratzer U; Schmidt WJ
Neurosci Lett; 1998 Aug; 252(1):53-6. PubMed ID: 9756357
[TBL] [Abstract][Full Text] [Related]
6. The effect of acamprosate on the development of morphine-induced behavioral sensitization in rats.
Kratzer U; Spanagel R; Schmidt WJ
Behav Pharmacol; 2003 Jul; 14(4):351-6. PubMed ID: 12838041
[TBL] [Abstract][Full Text] [Related]
7. Acamprosate does not antagonise the discriminative stimulus properties of amphetamine and morphine in rats.
Pascucci T; Cioli I; Pisetzky F; Duprè S; Spirito A; Nencini P
Pharmacol Res; 1999 Oct; 40(4):333-8. PubMed ID: 10527645
[TBL] [Abstract][Full Text] [Related]
8. Acamprosate suppresses ethanol-induced place preference in mice with ethanol physical dependence.
Kurokawa K; Mizuno K; Shibasaki M; Higashioka M; Oka M; Hirouchi M; Ohkuma S
J Pharmacol Sci; 2013; 122(4):289-98. PubMed ID: 23903008
[TBL] [Abstract][Full Text] [Related]
9. Acamprosate-responsive brain sites for suppression of ethanol intake and preference.
Brager A; Prosser RA; Glass JD
Am J Physiol Regul Integr Comp Physiol; 2011 Oct; 301(4):R1032-43. PubMed ID: 21697518
[TBL] [Abstract][Full Text] [Related]
10. Acamprosate (Campral) for alcoholism.
Conn Med; 2005 Apr; 69(4):227-8. PubMed ID: 15926637
[No Abstract] [Full Text] [Related]
11. Attenuation of cocaine-induced reinstatement of cocaine conditioned place preference by acamprosate.
Mcgeehan AJ; Olive MF
Behav Pharmacol; 2006 Jun; 17(4):363-7. PubMed ID: 16914955
[TBL] [Abstract][Full Text] [Related]
12. The effect of acamprosate on alcohol craving and correlation with hypothalamic pituitary adrenal (HPA) axis hormones and beta-endorphin.
Hammarberg A; Nylander I; Zhou Q; Jayaram-Lindström N; Reid MS; Franck J
Brain Res; 2009 Dec; 1305 Suppl():S2-6. PubMed ID: 19799882
[TBL] [Abstract][Full Text] [Related]
13. Effects of treatment with acamprosate on beta-endorphin plasma concentration in humans with high alcohol preference.
Kiefer F; Jahn H; Otte C; Nakovics H; Wiedemann K
Neurosci Lett; 2006 Aug; 404(1-2):103-6. PubMed ID: 16782270
[TBL] [Abstract][Full Text] [Related]
14. Repeated-testing of place preference expression for evaluation of anti-craving-drug effects.
Herzig V; Schmidt WJ
Amino Acids; 2005 May; 28(3):309-17. PubMed ID: 15791393
[TBL] [Abstract][Full Text] [Related]
15. [Acamprosate--new preclinical research aspects].
Spanagel R; Mann K
MMW Fortschr Med; 2003 Oct; 145 Suppl 3():61-4. PubMed ID: 15490768
[TBL] [Abstract][Full Text] [Related]
16. Lack of effects of acamprosate on anterior pituitary hormone secretion in healthy subjects.
Schüle C; Laakmann G; Baghai T; Neukam C; Soyka M
J Clin Psychopharmacol; 1999 Aug; 19(4):387-9. PubMed ID: 10440476
[No Abstract] [Full Text] [Related]
17. Acamprosate.
Nurs Times; 2005 Sep 6-12; 101(36):35. PubMed ID: 16163934
[No Abstract] [Full Text] [Related]
18. Effect of acamprosate on neonatal excitotoxic cortical lesions in in utero alcohol-exposed hamsters.
Adde-Michel C; Hennebert O; Laudenbach V; Marret S; Leroux P
Neurosci Lett; 2005 Feb; 374(2):109-12. PubMed ID: 15644274
[TBL] [Abstract][Full Text] [Related]
19. Schedule-induced alcohol drinking: non-selective effects of acamprosate and naltrexone.
Escher T; Mittleman G
Addict Biol; 2006 Mar; 11(1):55-63. PubMed ID: 16759337
[TBL] [Abstract][Full Text] [Related]
20. The glycine reuptake inhibitor Org24598 and acamprosate reduce ethanol intake in the rat; tolerance development to acamprosate but not to Org24598.
Lidö HH; Marston H; Ericson M; Söderpalm B
Addict Biol; 2012 Sep; 17(5):897-907. PubMed ID: 21955180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
